As of 2024-12-12, the Intrinsic Value of Kinarus Therapeutics Holding AG (KNRS.SW) is
-122.81 CHF. This KNRS.SW valuation is based on the model Peter Lynch Fair Value.
With the current market price of 14.80 CHF, the upside of Kinarus Therapeutics Holding AG is
-929.82%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-122.81 CHF
Intrinsic Value
KNRS.SW Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-122.81 - -122.81 |
-122.81 |
-929.82% |
| P/E |
(64.16) - (78.08) |
(72.63) |
-590.8% |
| DDM - Stable |
(586.95) - 4,667.77 |
2,040.41 |
13686.6% |
| DDM - Multi |
(568.35) - 3,567.55 |
(1,365.92) |
-9329.2% |
KNRS.SW Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
6.80 |
| Beta |
0.13 |
| Outstanding shares (mil) |
0.46 |
| Enterprise Value (mil) |
6.80 |
| Market risk premium |
5.10% |
| Cost of Equity |
5.51% |
| Cost of Debt |
5.00% |
| WACC |
5.03% |